Astaldi S p A Company Profile and SWOT Analysis Astaldi S p A Astaldi S p

Document Sample
Astaldi S p A Company Profile and SWOT Analysis Astaldi S p A Astaldi S p Powered By Docstoc
					Astaldi S.p.A.

_________________________________________________________________________________



Astaldi S.p.A.                                                                    Financial Snapshot

                                                                                  Operating Performance
Fast Facts
                                                                                  The company reported revenues of US$2,726.36
Headquarters Address                  Via G. V. Bona 65, Rome, 00156,Italy
                                                                                  million during 2010, with a CAGR of 19.19% during
                                                                                  2006–2010. Its revenue grew at an annual rate of
Telephone                             + 39 06 417661
                                                                                  4.86% over the previous fiscal year. In 2010, the
                                                                                  company recorded an operating margin of 8.49%, as
Fax                                   + 39 06 41766720                            against 8.42% in 2009.

Website                               www.astaldi.com
                                                                                  Revenue and Margins
Ticker Symbol, Stock Exchange         AST, Italian SE (Mercato Continuo Italia)

Number of Employees                   11,148

Fiscal Year End                       December

Revenue (in US$ million)              2,726.36

Revenue (in EUR million)              2,044.77




SWOT Analysis                                                                     Return on Equity

Strengths                             Weaknesses                                  The company recorded a return on equity (ROE) of
                                                                                  14.84% for 2010, as compared to its peers, Skanska
Consistent Growth in Net profits      Declining Market Share in Sector            AB (Ticker: SKAB), Maire Tecnimont S.p.A. (Ticker:
                                                                                  MT) and Impregilo S.p.A. (Ticker: IPG), which
                                                                                  recorded ROEs of 19.46%, 14.55% and 11.47%
Diversified Geographic Presence       Overdependence on One Sector                respectively. The company reported an operating
                                                                                  margin of 8.49% in 2010.
Strong Order Backlog
                                                                                  Return on Equity
Opportunities                         Threats

Construction Spending in Europe       Highly Competitive Industry

Demand Increase in Renewable
                                      Slowdown in Domestic Market
Energy
Infrastructure Market in Developing
Nations




                                                                                  Liquidity Position

                                                                                  The company reported a current ratio of 1.34 in 2010,
                                                                                  as compared to its peers, Skanska AB, Maire
                                                                                  Tecnimont S.p.A. and Impregilo S.p.A., which
                                                                                  recorded current ratios of 1.17, 1.04 and 1.31
                                                                                  respectively. As of December 2010, the company
                                                                                  recorded cash and short-term investments of worth
                                                                                  US$559.25 million, against US$457.70 million current
                                                                                  debt. The company reported a debt to equity ratio of
                                                                                  2.13 in 2010 as compared to its peers, Skanska AB,
                                                                                  Maire Tecnimont S.p.A. and Impregilo S.p.A., which
                                                                                  recorded debt to equity ratios of 0.07, 0.92 and 1.06
                                                                                  respectively.




___________________________________________________________________________________________

Astaldi S.p.A. - SWOT Profile                                                                                            Page 1
Astaldi S.p.A.

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................12
      2.2.4       Operational Efficiency ......................................................................................................................................13
      2.2.5       Solvency ..........................................................................................................................................................14
      2.2.6       Valuation ..........................................................................................................................................................15
    2.3       Competitive Benchmarking ..................................................................................................................................16
      2.3.1       Market Capitalization .......................................................................................................................................16
      2.3.2       Efficiency ..........................................................................................................................................................17
      2.3.3       Valuation ..........................................................................................................................................................18
      2.3.4       Turnover – Inventory and Asset .......................................................................................................................19
      2.3.5    
				
DOCUMENT INFO
Description: This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. ICD Research's "Astaldi S.p.A.: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
BUY THIS DOCUMENT NOW PRICE: $99 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.